Glenmark Pharmaceuticals Inc., has been granted final approval by the United States Food & Drug Administration (US FDA) for Colesevelam Hydrochloride for Oral Suspension, 1.875 grams/Packet...
Zydus Cadila has received the final approval from the USFDA to market Clindamycin Phosphate Topical Solution USP (Cleocin T), 1 percent. Clindamycin is an antibiotic which...
Ajanta Pharma Ltd has come under the regulator’s scanner for allegedly selling unapproved fixed-dose combinations (FDCs) manufactured by a Puducherry firm. While a complaint has been...
Agilent Technologies Inc. announced that it has completed the acquisition of the business assets of ULTRA Scientific, Inc., a leading provider of chemical standards and certified...
Johnson & Johnson announced sales of USD 20.8 billion for the second quarter of 2018, an increase of 10.6 percent as compared to the second quarter of 2017....
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that on Wednesday, August 1, 2018, after market close, the Company will release...
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, will report financial results for the second quarter 2018 on Tuesday, August...
Pfizer Inc. and Spark Therapeutics announced that Pfizer initiated a Phase 3 open-label, multi-center, lead-in study (NCT03587116) to evaluate the efficacy and safety of current factor...
AbbVie announced patent license agreements with Mylan over its proposed biosimilar adalimumab product. Under the terms of the agreements, AbbVie will grant Mylan a non-exclusive license...
UnitedHealth Group reported second quarter results, with continued strong, well-diversified performance across the enterprise. “Today, UnitedHealth Group delivers increasing value to more people, driven by strong...
Agility Health, Inc. is pleased to announce that it is undertaking a non-brokered private placement offering of a maximum of 30,000,000 units at a price of...
Cerner Corporation announced it will release its second quarter 2018 earnings results after the market closes Thursday, August 2. Following the release, the company will hold...
There are thousands of complications that a human body can suffer from, and that makes for hundreds of different types of diagnostic imaging that are needed...
In terms of value, the global disposable laparoscopic instruments market is projected to register a healthy CAGR of 5.7 percent till 2028 due to various factors....
The global electroceutical devices market was valued USD 17.8 billion in 2018, and is projected to exhibit a CAGR of 8.0 percent from 2018 – 2026....
Copyright © 2024 Medical Buyer